January 29, 2018 / 7:42 AM / a month ago

Ablynx shares suspended after Sanofi bid - regulator

BRUSSELS (Reuters) - Shares of Belgian biotech group Ablynx (ABLX.BR) will be suspended until 1030 local time (0930 GMT), following a 45 euros epr share bid by French pharma group Sanofi (SASY.PA), the Belgian market regulator said.

The shares were suspended to allow an “adequate dissemination of a press release”, the regulator said in a statement.

Reporting by Robert-Jan Bartunek; editing by Philip Blenkinsop

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below